Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.50 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TOP1 | P11387 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1302237 | 1.00 | FAAH (0.50) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL29080381 | 1.00 | FAAH (0.50) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL1302086 | 0.98 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL1301613 | 0.98 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL1302487 | 0.98 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL18837285 | 0.98 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL10386003 | 0.98 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL1302485 | 0.98 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL11804580 | 0.98 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL3506667 | 0.98 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112868654-B | Honeybee repellent as well as preparation method and application thereof | 中国科学院西双版纳热带植物园 | 2022-03-04 | — | — | CN | claimed |
| CN-112868654-A | Bee repellent and preparation method and application thereof | 中国科学院西双版纳热带植物园 | 2021-06-01 | — | — | CN | claimed |
| CN-101400408-A | Compositions and methods for eliminating oral malodour | GIVAUDAN SA (CH) | 2009-04-01 | — | — | CN | claimed |
| CN-101394897-A | Compositions and methods to counteract oral malodour | GIVAUDAN SA (CH) | 2009-03-25 | — | — | CN | claimed |
| US-20080311054-A1 | Compositions and Methods to Counteract Oral Malodour | GIVAUDAN SA (CH) | 2008-12-18 | — | — | US | claimed |
| US-20080247966-A1 | Compositions and Methods to Counteract Oral Malodour | GIVAUDAN SA (CH) | 2008-10-09 | — | — | US | claimed |
| EP-1937365-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | Givaudan SA (CH) | 2008-07-02 | — | — | EP | claimed |
| EP-1919566-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | Givaudan SA (CH) | 2008-05-14 | — | — | EP | claimed |
| WO-2007025402-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | GIVAUDAN SA (CH) | 2007-03-08 | — | — | WO | claimed |
| WO-2007025401-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | GIVAUDAN SA (CH) | 2007-03-08 | — | — | WO | claimed |
| US-5118837-A | Reaction of olefinic double bond in presence of other, less reactive olefinic double bonds; modified ruthenium catalyst with trivalent phosphorus or nitrogen or divalent sulfur compound | GIVAUDAN CORPORATION (US) | 1992-06-02 | — | — | US | claimed |
| JP-8325106-A | — | — | None | — | — | JP | disclosed |
| WO-2025128988-A1 | ATTRACTANT COTTON SEED BUG, OXYCARENUS HYALINIPENNIS, AND USES THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2025-06-19 | — | — | WO | disclosed |
| US-20250194594-A1 | ATTRACTANT COTTON SEED BUG, OXYCARENUS Hyalinipennis, AND USES THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2025-06-19 | — | — | US | disclosed |
| WO-2025096734-A1 | MICROCAPSULES | FMC CORPORATION (US) | 2025-05-08 | — | — | WO | disclosed |
| JP-2005068022-A | REPELLENT FOR LEPTOCORSIA CHINENSIS | SUMITOMO CHEMICAL CO LTD | 2005-03-17 | — | — | JP | disclosed |
| US-5981792-A | Process for the production of 1-functional allylalcohol carboxylic esters | DRAGOCO GERBERDING & CO. AG (DE) | 1999-11-09 | — | — | US | disclosed |
| JP-H08325106-A | ATTRACTANT FOR LEPTOCORISA CHINENSIS | NORIN SUISANSYO SANSHI KONCHU NOGYO GIJUTSU KENKYUSHO | 1996-12-10 | — | — | JP | disclosed |
| US-5118837-A | Reaction of olefinic double bond in presence of other, less reactive olefinic double bonds; modified ruthenium catalyst with trivalent phosphorus or nitrogen or divalent sulfur compound | GIVAUDAN CORPORATION (US) | 1992-06-02 | — | — | US | disclosed |
| US-3949007-A | METAL HYDROXIDE OR ALKOXIDE CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311054-A1 | Compositions and Methods to Counteract Oral Malodour | TAS2R60, TAS2R40, LPO | FAAH 1457/4885TERT 2154/4885PTPN1 3708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.